Communication is the best cureExamples of healthcare outcomes being dependent on successful communication are not just numerous; they are ubiquitous.Paul Hayhow
What does the future hold for clinical trial recruitment?The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in pharmaceutical development.Paul Hayhow
Why big Pharma needs to be braverOver the decades, the pharmaceutical industry has settled. The old adage, “if it’s not broke, don’t fix it,” has seemingly become a motto of the industry when it communicates with healthcare professionals (HCPs). But the safe and dull doesn’t inspire, it does not engage, and it does not evoke reactions. However, adopting a creative communication style can help overcome this hurdle.Paul Hayhow
How scientific storytelling can help pharma cut through the noiseFor many in the pharmaceutical industry, hearing the word ‘storytelling’ in the context of their business might send shivers down their spines. The inference of tall tales, narratives and plots may feel a million miles away from the statistics, evidence and facts that underpin their drug development.Paul Hayhow
How healthcare comms can better support clinical trial recruitmentClinical trials once rarely made the headlines – unless something went drastically wrong – but the past couple of years has changed all that. Amid the full blaze of the pandemic, we saw queues round the block as people volunteered to take part in vaccine clinical trials. The necessity and value of testing new vaccines was particularly evident as the Covid-19 health crisis first gripped nations across the world. And work on vaccines continues – last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant.Paul Hayhow
How can pharma companies help HCPs face Dr. Google?A correct diagnosis can sometimes take time and patients often look for online support groups and communities to help so improving communications around health and wellbeing is the most effective way to mitigate against the rise of ‘cyberchondria’ born from self-diagnosis and Dr. Google.Paul Hayhow
Treatment for all: The key steps to better representation in pharmaThe pharma industry has a lot of work to improve inclusion, clinical trials are clearly the first port of call and an important step to achieving treatment for all.Paul Hayhow
Making diversity and inclusion a core part of pharma’s DNAWe brought together a group of industry experts for our latest Media Lab workshop to discuss the process of making diversity and inclusion (D&I) a core part of pharma’s DNA. We covered how to build and nurture a diverse workforce, measure the progress and how to embed D&I in the DNA of companies.Paul Hayhow
Using patients’ experience to set the pace of therapeutic advancesIn a recent Media Lab workshop, a group of industry experts came together to discuss the importance of understanding the patient’s experience, covering everything from the power of patient insights and working with patient associations, to the role of data and technology innovation in diagnostics, treatment and prevention.Paul Hayhow